Clariant AG: Clariant welcomes Britta Fuenfstueck as new member of the Executive Committee

Clariant AG / Clariant AG: Clariant welcomes Britta Fuenfstueck as new member of the Executive Committee . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Muttenz, January 28, 2016 - Clariant, a world leader in specialty chemicals, announced today the appointment of Britta Fuenfstueck as a new member of its Executive Committee. Britta Fuenfstueck, former CEO of the Clinical Products Division at Siemens Healthcare, will join Clariant on April 1, 2016.

"We are very pleased that Britta Fuenfstueck will join Clariant. With her extensive international experience as a senior executive in the technology industry, she will be a strong addition to our management team and will bring valuable insights and perspectives," said Hariolf Kottmann, CEO. "I look forward to Britta Fuenfstueck's contributions toward the long-term development of Clariant and her support for our top priority: to generate value for our customers, our employees, our company, and our shareholders."

Britta Fuenfstueck (43) has been CEO of the Clinical Products Division at Siemens Healthcare since 2013. During her career with Siemens, she held various leadership positions, including CEO of the Molecular Imaging Business Unit, Vice President, Strategy and M&A for the Healthcare Sector, as well as Director, Product Portfolio and Planning, Marketing and Sales, for Siemens' Magnetic Resonance Business Unit. Britta Fuenfstueck studied engineering physics at the Johannes Kepler University in Linz, Austria. She began her career with the Boston Consulting Group in 1998.

As of April 1, 2016, the Executive Committee of Clariant will consist of CEO Hariolf Kottmann, CFO Patrick Jany, Britta Fuenfstueck, and Christian Kohlpaintner.

Press Release Deutsch (http://hugin.info/100166/R/1981739/726089.pdf)
Press Release English (http://hugin.info/100166/R/1981739/726088.pdf)

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Clariant AG via Globenewswire

HUG#1981739

--- End of Message ---

Clariant AG
Rothausstrasse 61 Muttenz 1 Switzerland

ISIN: CH0012142631;